• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用国民健康保险服务-全国样本队列(NHIS-NSC)数据库对韩国经皮冠状动脉介入治疗现状的描述性研究:聚焦时间趋势

Descriptive Study on the Korean Status of Percutaneous Coronary Intervention Using National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database: Focused on Temporal Trend.

作者信息

Sung Jidong, Hong Kyung Pyo

机构信息

Division of Cardiology, Department of Medicine, Prevention & Rehabilitation Center, Heart Vascular & Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean Circ J. 2019 Dec;49(12):1155-1163. doi: 10.4070/kcj.2019.0080. Epub 2019 Aug 2.

DOI:10.4070/kcj.2019.0080
PMID:31456371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6875599/
Abstract

BACKGROUND AND OBJECTIVES

Percutaneous coronary intervention (PCI) is an indispensable treatment modality in coronary artery disease. However, there is still inadequacy of comprehensive knowledge on the Korean status and trend of this important procedure using nation-wide and representative data.

METHODS

National Health Insurance Service-National Sample Cohort is a database containing demographic, health insurance reimbursement for patient management and health screening data of about one million Koreans for 12 years (2002-2013). Annual procedure rate for PCI was estimated by bootstrapping as per 100,000 person-years.

RESULTS

Among the whole cohort, total 12,186 PCI's were done during the study period. Mean age of subjects who underwent PCI was 57.6±11.2 years and male:female proportion was 68%:32%. Death from all cause occurred in 1,843 (15.1%), death from ischemic heart diseases in 662 (5.4%), death from all cardiovascular cause in 872 (7.2%) during the follow-up. The proportion of the primary PCI for acute myocardial infarction was estimated to be 24.0%. Estimated annual rate of PCI increased from median 29.1 (95% confidence interval [CI], 26.6-32.1) in 2002 to 107.7 (95% CI, 103.0-113.8) per 100,000 person-years in 2013. In this cohort, PCI was performed in total 180 hospitals, which annually increased from 59 in 2002 to 153 in 2013.

CONCLUSIONS

PCI had increased in volume from 2002 to 2013. This descriptive data may be considered in policy making and planning further direction of management of coronary artery disease in Korea.

摘要

背景与目的

经皮冠状动脉介入治疗(PCI)是冠状动脉疾病不可或缺的治疗方式。然而,利用全国性且具有代表性的数据,对于这一重要治疗手段在韩国的现状及趋势,仍缺乏全面的了解。

方法

国民健康保险服务 - 全国样本队列是一个数据库,包含约100万韩国人的人口统计学信息、患者管理的健康保险报销情况以及12年(2002 - 2013年)的健康筛查数据。PCI的年手术率通过自抽样法按每10万人年进行估算。

结果

在整个队列中,研究期间共进行了12,186例PCI手术。接受PCI治疗的患者平均年龄为57.6±11.2岁,男性与女性比例为68%:32%。随访期间,全因死亡1,843例(15.1%),缺血性心脏病死亡662例(5.4%),所有心血管原因导致的死亡872例(7.2%)。急性心肌梗死的直接PCI比例估计为24.0%。PCI的估计年手术率从2002年的中位数29.1(95%置信区间[CI],26.6 - 32.1)增加到2013年的每10万人年107.7(95%CI,103.0 - 113.8)。在这个队列中,共有180家医院进行了PCI手术,每年从2002年的59家增加到2013年的153家。

结论

2002年至2013年期间,PCI的手术量有所增加。在韩国制定冠状动脉疾病管理的政策及规划进一步方向时,可考虑这些描述性数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/6875599/1b367b3c787f/kcj-49-1155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/6875599/1b367b3c787f/kcj-49-1155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bf/6875599/1b367b3c787f/kcj-49-1155-g001.jpg

相似文献

1
Descriptive Study on the Korean Status of Percutaneous Coronary Intervention Using National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database: Focused on Temporal Trend.利用国民健康保险服务-全国样本队列(NHIS-NSC)数据库对韩国经皮冠状动脉介入治疗现状的描述性研究:聚焦时间趋势
Korean Circ J. 2019 Dec;49(12):1155-1163. doi: 10.4070/kcj.2019.0080. Epub 2019 Aug 2.
2
Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea.2006年至2010年韩国冠状动脉血运重建术的实践变化。
Yonsei Med J. 2015 Jul;56(4):895-903. doi: 10.3349/ymj.2015.56.4.895.
3
Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database.经皮冠状动脉介入治疗后西洛他唑或沙格雷酯联合阿司匹林和氯吡格雷的抗血小板治疗:一项使用韩国国民健康保险索赔数据库的回顾性队列研究
PLoS One. 2016 Mar 3;11(3):e0150475. doi: 10.1371/journal.pone.0150475. eCollection 2016.
4
Total Center Percutaneous Coronary Intervention Volume and 30-Day Mortality: A Contemporary National Cohort Study of 427 467 Elective, Urgent, and Emergency Cases.全中心经皮冠状动脉介入治疗量与30天死亡率:一项对427467例择期、紧急和急诊病例的当代全国队列研究。
Circ Cardiovasc Qual Outcomes. 2017 Mar;10(3). doi: 10.1161/CIRCOUTCOMES.116.003186.
5
Trends in Percutaneous Coronary Intervention and Coronary Artery Bypass Surgery in Korea.韩国经皮冠状动脉介入治疗和冠状动脉旁路移植术的趋势
Korean J Thorac Cardiovasc Surg. 2016 Dec;49(Suppl 1):S60-S67. doi: 10.5090/kjtcs.2016.49.S1.S60. Epub 2016 Dec 5.
6
Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.中国非急性心肌梗死患者的经皮冠状动脉介入治疗:来自中国经皮冠状动脉介入治疗前瞻性研究(China PEACE)的结果。
JAMA Netw Open. 2018 Dec 7;1(8):e185446. doi: 10.1001/jamanetworkopen.2018.5446.
7
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.韩国经皮冠状动脉介入治疗的现状:基于2014年韩国经皮冠状动脉介入治疗(K-PCI)注册研究队列
Korean Circ J. 2017 May;47(3):328-340. doi: 10.4070/kcj.2017.0071. Epub 2017 May 25.
8
Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.在患有 CKD 的心血管风险亚组患者中,药物治疗、经皮血运重建和冠状动脉旁路移植术的比较效果:医疗保险受益人的回顾性队列研究。
Am J Kidney Dis. 2019 Oct;74(4):463-473. doi: 10.1053/j.ajkd.2019.04.018. Epub 2019 Jun 27.
9
Relationship between time to treatment and mortality among patients undergoing primary percutaneous coronary intervention according to Korea Acute Myocardial Infarction Registry.根据韩国急性心肌梗死登记处的数据,接受直接经皮冠状动脉介入治疗的患者中治疗时间与死亡率之间的关系。
J Cardiol. 2017 Jan;69(1):377-382. doi: 10.1016/j.jjcc.2016.09.002. Epub 2016 Oct 6.
10
Percutaneous coronary intervention in patients with acute coronary syndrome in Chinese Military Hospitals, 2011-2014: a retrospective observational study of a national registry.2011-2014 年中国军队医院急性冠脉综合征患者经皮冠状动脉介入治疗:一项全国注册登记的回顾性观察研究。
BMJ Open. 2018 Oct 24;8(10):e023133. doi: 10.1136/bmjopen-2018-023133.

引用本文的文献

1
Off-hour presentation and outcomes for percutaneous coronary intervention in acute myocardial infarction with Killip III-IV.急性心肌梗死伴 Killip III-IV 级行经皮冠状动脉介入治疗的非工作时间手术与结局。
Korean J Intern Med. 2022 May;37(3):591-604. doi: 10.3904/kjim.2021.539. Epub 2022 Apr 28.
2
Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study.严重高胆固醇血症的心血管风险和治疗结果:一项全国性队列研究。
J Am Heart Assoc. 2022 May 3;11(9):e024379. doi: 10.1161/JAHA.121.024379. Epub 2022 Apr 26.
3
Outcomes of Nonagenarians with Acute Myocardial Infarction with or without Coronary Intervention.

本文引用的文献

1
Percutaneous coronary intervention for stable coronary artery disease.经皮冠状动脉介入治疗稳定型冠状动脉疾病。
Heart. 2019 Jan;105(1):11-19. doi: 10.1136/heartjnl-2017-312755. Epub 2018 Sep 21.
2
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry.韩国经皮冠状动脉介入治疗的现状:基于2014年韩国经皮冠状动脉介入治疗(K-PCI)注册研究队列
Korean Circ J. 2017 May;47(3):328-340. doi: 10.4070/kcj.2017.0071. Epub 2017 May 25.
3
Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data.
九旬老人急性心肌梗死接受或未接受冠状动脉介入治疗的结局
J Clin Med. 2022 Mar 14;11(6):1593. doi: 10.3390/jcm11061593.
4
Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time.根据就诊时间治疗 ST 段抬高型心肌梗死患者的长期结局。
Korean J Intern Med. 2022 May;37(3):605-617. doi: 10.3904/kjim.2021.204. Epub 2021 Nov 16.
5
Long-Term Benefit and Withdrawal Effect of Statins After Percutaneous Coronary Intervention: A Nationwide Population-Based Cohort Study.经皮冠状动脉介入治疗后他汀类药物的长期获益及撤药效应:一项基于全国人口的队列研究
Patient Prefer Adherence. 2020 Apr 5;14:717-724. doi: 10.2147/PPA.S245324. eCollection 2020.
6
The Need for Re-evaluation of PCI Practice: from Proceduralists to Clinicians.重新评估PCI实践的必要性:从介入医生到临床医生
Korean Circ J. 2019 Dec;49(12):1164-1166. doi: 10.4070/kcj.2019.0286. Epub 2019 Sep 30.
实现韩国健康保险审查与评估(HIRA)数据作为健康研究资源的价值潜力:HIRA数据的优势、局限性、应用及最佳使用策略
J Korean Med Sci. 2017 May;32(5):718-728. doi: 10.3346/jkms.2017.32.5.718.
4
Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United States.美国有和无院内心脏外科手术的中心行经皮冠状动脉介入治疗的结局和时间趋势。
JAMA Cardiol. 2017 Jan 1;2(1):25-33. doi: 10.1001/jamacardio.2016.4188.
5
Socioeconomic Inequality in mortality using 12-year follow-up data from nationally representative surveys in South Korea.利用韩国全国代表性调查的12年随访数据研究死亡率方面的社会经济不平等。
Int J Equity Health. 2016 Mar 22;15:51. doi: 10.1186/s12939-016-0341-9.
6
Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.队列简介:韩国国民健康保险服务国家样本队列(NHIS-NSC)
Int J Epidemiol. 2017 Apr 1;46(2):e15. doi: 10.1093/ije/dyv319.
7
Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea.2006年至2010年韩国冠状动脉血运重建术的实践变化。
Yonsei Med J. 2015 Jul;56(4):895-903. doi: 10.3349/ymj.2015.56.4.895.
8
Socioeconomic inequalities in quality of care and outcomes among patients with acute coronary syndrome in the modern era of drug eluting stents.药物洗脱支架现代时代急性冠状动脉综合征患者护理质量和治疗结果中的社会经济不平等
J Am Heart Assoc. 2014 Nov 14;3(6):e001029. doi: 10.1161/JAHA.114.001029.
9
Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011).美国经皮冠状动脉介入治疗用于急性冠状动脉综合征和稳定型冠状动脉疾病的管理(2007 年至 2011 年)。
Am J Cardiol. 2014 Oct 1;114(7):1003-10. doi: 10.1016/j.amjcard.2014.07.013. Epub 2014 Jul 18.
10
Validity of the diagnosis of acute myocardial infarction in korean national medical health insurance claims data: the korean heart study (1).韩国国家医疗保险索赔数据中急性心肌梗死诊断的有效性:韩国心脏研究(1)。
Korean Circ J. 2012 Jan;42(1):10-5. doi: 10.4070/kcj.2012.42.1.10. Epub 2012 Jan 31.